MAHENDER SURAKANTI: Open Payments
NPI 1417940909 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 172 payments from 15 companies in 2025. Trend: 2023 $1,814 · 2024 $1,949 · 2025 $2,753
Food & beverage: $2,642Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $335 |
| Teva Pharmaceuticals USA, Inc. | 15 | $327 |
| Lundbeck LLC | 23 | $321 |
| Alkermes, Inc. | 24 | $304 |
| ABBVIE INC. | 31 | $287 |
| E.R. Squibb & Sons, L.L.C. | 16 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $195 |
| Neurocrine BioSciences, Inc. | 9 | $180 |
| Corium, LLC | 6 | $150 |
| Axsome Therapeutics, Inc. | 6 | $144 |
Products named: REXULTI, ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, COBENFY, Azstarys, Auvelity.
Industry payments across IN — which companies pay providers there.
